Medindia

X

MAP Pharmaceuticals Submits New Drug Application to FDA for LEVADEX® Orally Inhaled Migraine Drug

Friday, May 27, 2011 General News J E 4
Advertisement

CONTACT:

Nicole Foderaro

Lisa Borland

WCG

MAP Pharmaceuticals, Inc.

(415) 946-1058

650-386-3122

nfoderaro@wcgworld.com

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Smile Train Partner G S Memorial Reaches Major Mil...
S
Centene Corporation to Present at Goldman Sachs 20...